RUNX2 and breast cancer: Interestingly, it has been shown that ERα interacts with RUNX2 in MCF7 breast cancer cell line, and the MC3T3-E1 pre-osteoblast cell line, and that this interaction was estrogen dependant, and resulted in the inhibition of RUNX2 activity [43].